PA
BSX icon

Pinnacle Associates’s Boston Scientific BSX Stock Holding History

Pinnacle Associates’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$713K Buy
16,713
+2,720
+19% +$148K 0.01% 607
2026
Q1 		$878K Buy
13,993
+6,232
+80% +$499K 0.01% 541
2025
Q4 		$740K Sell
7,761
-12
-0.2% -$1.18K 0.01% 576
2025
Q3 		$759K Sell
7,773
-315
-4% -$32.6K 0.01% 556
2025
Q2 		$869K Buy
8,088
+404
+5% +$40.9K 0.01% 535
2025
Q1 		$775K Sell
7,684
-232
-3% -$23.4K 0.01% 530
2024
Q4 		$707K Buy
7,916
+586
+8% +$51.6K 0.01% 536
2024
Q3 		$424K Sell
7,330
-438
-6% -$34.5K 0.01% 603
2024
Q2 		$598K Buy
7,768
+290
+4% +$21.2K 0.01% 550
2024
Q1 		$512K Buy
7,478
+148
+2% +$9.52K 0.01% 581
2023
Q4 		$424K Buy
7,330
+77
+1% +$4.11K 0.01% 611
2023
Q3 		$383K Sell
7,253
-179
-2% -$9.39K 0.01% 612
2023
Q2 		$402K Buy
7,432
+343
+5% +$17.9K 0.01% 611
2023
Q1 		$355K Buy
7,089
+287
+4% +$13.5K 0.01% 589
2022
Q4 		$315K Buy
6,802
+1,189
+21% +$51.5K 0.01% 593
2022
Q3 		$217K Buy
+5,613
New +$225K 0.01% 677

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Pinnacle Associates's BSX Position: Q2 2026 in Review

Pinnacle Associates increased its Boston Scientific (BSX) stake by 19% in Q2 2026, buying an estimated $148K and bringing the position to 16,713 shares worth $713K. The position accounts for 0.01% of the portfolio, ranked #607.

Pinnacle Associates first reported a position in BSX in Q3 2022 and has held it in 16 quarters since. The position peaked at $878K in Q1 2026. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Pinnacle Associates held 16,713 shares of Boston Scientific worth $713K as of Q2 2026.
  • Pinnacle Associates bought 2,720 Boston Scientific shares in Q2 2026, an estimated $148K.
  • Boston Scientific made up 0.01% of Pinnacle Associates's portfolio in Q2 2026, its #607 holding.
  • Pinnacle Associates first reported a position in Boston Scientific in Q3 2022 and has held it in 16 quarters since.
  • Pinnacle Associates's Boston Scientific position peaked at $878K in Q1 2026.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Pinnacle Associates's 13F filing for Q2 2026, filed 3 Aug 2026.